For decades, HIV treatment has depended on one hard truth: once medication stops, the virus usually comes roaring back. Modern antiretroviral drugs can suppress HIV so effectively that many people ...

Asher Biotherapeutics (Asher Bio), a clinical-stage biotechnology company developing precisely-targeted immunotherapies for cancer, today announced two upcoming presentations at the 2026 American ...

The once-crowded field for the Democratic candidate in one of the nation's most competitive congressional districts has ...

A preclinical mouse study in Immunity suggests that aged circulating CD8+ T cells can disrupt hippocampal function and impair ...

That leaves two Democrats, former state Rep. Shannon Bird of Westminster and state Rep. Manny Rutinel of Commerce City, vying ...

Anaveon, a late-stage preclinical biotechnology company focused on reprogramming the immune system for the treatment of autoimmune and inflammatory diseases, today announced that new clinical data ...

Targeted extended circulation LNP incorporating DARPins achieved complete B cell depletion in nonhuman primates through highly specific in vivo CD8+ T cell engineeringRobust study quantifies ...

Orphan Drug Designation confers regulatory, financial and strategic advantagesEO2463 has shown potentially disease modifying activity in clinical ...

Researchers found that lowering MHC I can expose cancerous or foreign cells to CD4+ T cell attack, reshaping assumptions ...